OT

Enjoy food and beverage in the Expo Hall while networking with exhibitors and attendees.

In this powerful keynote from the patient’s perspective, John shares the extraordinary journey of receiving a heart transplant at age 60-and the nearly one billion more heartbeats that symbolize a second chance at life. Blending his personal story with reflections on resilience, recovery and hope, John offers a unique and deeply human perspective on the impact of healthcare, the power of science , and the grace required to bounce back.

In this keynote presentation, Brendan O'Callaghan, Executive Vice President of Manufacturing & Supply at Sanofi, will share insights into Sanofi's modernization journey and how the company is embracing a Digital-first, Data-driven, and AI-enabled strategy in a Pharma 4.0 world. The presentation will explore how Sanofi is leveraging Digital, Data, and AI to revolutionize manufacturing processes and speed the delivery of innovative medicines and vaccines to patients.

Refreshments offered, including non-alcoholic beverages and light snacks.

The ICH Q14 guideline provides a science- and risk-based approach to developing and maintaining analytical procedures, ensuring they remain fit for purpose throughout a drug’s lifecycle. However, implementing changes to analytical procedures remains complex due to regulatory variations across global markets. The adoption of ICH Q14, alongside principles from ICH Q12, offers the promise of a streamlined postapproval change management process that reduces regulatory burden while maintaining compliance.